Belvedere Trading LLC Insmed Inc Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Nov 01, 2024
BUY
$22.0 - $69.71 $101,728 - $322,339
4,624 New
4,624 $309,000
Q2 2024

Aug 09, 2024
SELL
$22.0 - $69.71 $284,768 - $902,326
-12,944 Reduced 73.68%
4,624 $309,000
Q1 2024

May 09, 2024
BUY
$25.72 - $29.94 $451,848 - $525,985
17,568 New
17,568 $476,000
Q3 2023

Oct 27, 2023
BUY
$19.86 - $26.93 $53,959 - $73,168
2,717 New
2,717 $68,000

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email